ACONNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as ACONW
Aclarion, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.89+0.04 (+2.16%)
Close on Oct 19, 2026
- Market cap
- $4.65M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
0M
Shares held, 13F filers
Institutional holders
15
7 new, 2 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
11 buys · 0 sales
Net bought $176.65K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| SEG Opportunity Fund, LLC | 244,043 | 9.98% | 13G (passive) | Mar 25, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ACON | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Bridgeway Capital Management, LLC | 19,480 | – | $56.10K | New | 0.00% |
| Captrust Financial Advisors | 17,059 | – | $49.13K | +2,500 | 0.00% |
| Vanguard Fiduciary Trust Co | 16,028 | – | $46.16K | New | 0.00% |
| Susquehanna International Group, Llp | 15,355 | – | $44.22K | New | 0.00% |
| Geode Capital Management, LLC | 12,128 | – | $34.93K | −19,087 | 0.00% |
| XTX Topco Ltd | 11,038 | – | $31.79K | New | 0.00% |
| Bank Of Montreal /Can/ | 10,000 | – | $28.80K | – | 0.00% |
| Vanguard Capital Management LLC | 6,782 | – | $19.53K | – | 0.00% |
| Osaic Holdings, Inc. | 5,000 | – | $14.40K | −29,945 | 0.00% |
| UBS Group AG | 1,968 | – | $5.67K | −7,679 | 0.00% |
| Barclays PLC | 283 | – | $815 | New | 0.00% |
| Clear Street Group Inc. | 103 | – | $297 | +100 | 0.00% |
| Wells Fargo & Company/Mn | 100 | – | $288 | New | 0.00% |
| Caitong International Asset Management Co., Ltd | 4 | – | $12 | New | 0.00% |
| Danske Bank A/S | 1 | – | $3 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 15 | 0M | 7 / 2 | 3 / 2 | 0M | 0M |
| Q1 2026 | 10 | 0M | 4 / 2 | 0 / 2 | 0M | 0M |
| Q4 2025 | 8 | 0M | 2 / 1 | 1 / 2 | 0M | 0M |
| Q3 2025 | 8 | 0M | 5 / 1 | 0 / 1 | 0M | 0M |
| Q2 2025 | 5 | 0M | 0 / 3 | 0 / 1 | 0M | 0M |
| Q1 2025 | 6 | 0M | 6 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of ACON | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 21,944 | – | $71.98K | 0.00% | May 31, 2026 |
| Ultra-Small Company Fund | 19,480 | – | $56.10K | 0.06% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 6,782 | – | $19.53K | 0.00% | Jun 30, 2026 |
| Fidelity Series Total Market Index Fund | 477 | – | $1.56K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Brent Ness | Chief Executive Officer, Director | 111,534 | Aug 17, 2026 |
| Jeffrey John Thramann | Executive Chairman, Director | 100,000 | Jun 12, 2026 |
| Gregory A. Gould | CFO | 60,000 | Aug 18, 2026 |
| Amanda Mae Sequira | Director | 25,857 | Aug 19, 2026 |
| William Wesemann | Director | 23,713 | Aug 17, 2026 |
| David K. Neal | Director | 30,002 | Aug 17, 2026 |
| Ryan Bond | Director | 76,122 | Aug 17, 2026 |
| Stephen Deitsch | Director | 20,000 | Jun 12, 2026 |
| Scott Breidbart | Director | 25,664 | Jun 12, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Amanda Mae Sequira Director | Aug 17, 2026 | Buy | +5,857 | $2.73 | $15.99K | 25,857 |
| Gregory A. Gould CFO | Aug 14, 2026 | Buy | +10,000 | $2.45 | $24.50K | 60,000 |
| Brent Ness Chief Executive Officer, Director | Aug 13, 2026 | Buy | +5,234 | $2.31 | $12.09K | 111,534 |
| William Wesemann Director | Aug 13, 2026 | Buy | +2,150 | $2.34 | $5.03K | 23,713 |
| Ryan Bond Director | Aug 13, 2026 | Buy | +21,122 | $2.37 | $50.06K | 76,122 |
| David K. Neal Director | Aug 13, 2026 | Buy | +7,500 | $2.40 | $18.00K | 30,002 |
| Stephen Deitsch Director | Jun 11, 2026 | Award | +20,000 | – | – | 20,000 |
| David K. Neal Director | Jun 11, 2026 | Award | +20,000 | – | – | 22,502 |
| Ryan Bond Chief Strategy Officer | Jun 11, 2026 | Award | +55,000 | – | – | 55,000 |
| Jeffrey John Thramann Executive Chairman, Director | Jun 11, 2026 | Award | +100,000 | – | – | 100,000 |
| Gregory A. Gould Chief Financial Officer | Jun 11, 2026 | Award | +50,000 | – | – | 50,000 |
| William Wesemann Director | Jun 11, 2026 | Award | +20,000 | – | – | 21,563 |
| Brent Ness Chief Executive Officer, Director | Jun 11, 2026 | Award | +100,000 | – | – | 106,300 |
| Amanda Mae Sequira Director | Jun 11, 2026 | Award | +20,000 | – | – | 20,000 |
| Scott Breidbart Director | Jun 11, 2026 | Award | +20,000 | – | – | 25,664 |
| Scott Breidbart Director | May 12, 2026 | Buy | +5,664 | $3.18 | $18.01K | 5,664 |
| David K. Neal Director | May 11, 2026 | Buy | +2,500 | $3.10 | $7.75K | 2,502 |
| Brent Ness Chief Executive Officer, Director | May 11, 2026 | Buy | +6,289 | $3.18 | $20.00K | 6,300 |
| William Wesemann Director | May 6, 2026 | Buy | +1,562 | $3.30 | $5.15K | 1,563 |
| Brent Ness Chief Executive Officer, Director | Nov 26, 2025 | Buy | +10 | $6.20 | $62 | 11 |
| Jeffrey John Thramann Executive Chairman | Mar 28, 2023 | Other | −1 | $1000.00 | $1.00K | 0 |
| Jeffrey John Thramann Executive Chairman, Director | Feb 16, 2023 | Buy | +1 | $1000.00 | $1.00K | 1 |
| John Paul Lorbiecki Chief Financial Officer | Dec 29, 2022 | Buy | +4,100 | $0.43 | $1.76K | 4,100 |
| John Paul Lorbiecki Chief Financial Officer | Dec 29, 2022 | Buy | +18,304.44 | $0.45 | $8.24K | 22,404 |
| Brent Ness Chief Executive Officer, Director | Dec 29, 2022 | Buy | +8,500 | $0.51 | $4.34K | 11,789 |
| Brent Ness Chief Executive Officer, Director | Dec 29, 2022 | Buy | +7,711 | $0.58 | $4.47K | 19,500 |
| Brent Ness Chief Executive Officer, Director | Dec 28, 2022 | Buy | +2,289 | $0.42 | $961 | 3,289 |
| David K. Neal Director | Dec 2, 2022 | Other | +152,128 | – | – | 186,528 |
| David K. Neal Director | Dec 2, 2022 | Other | −152,128 | – | – | 186,528 |
| Michael W. Dirks – | Dec 2, 2022 | Other | −1,091,894 | – | – | 0 |
| Ryan Bond Chief Strategy Officer | Apr 22, 2022 | Buy | +20,000 | $2.80 | $56.00K | 20,000 |
| Brent Ness Chief Executive Officer, Director | Apr 21, 2022 | Buy | +1,000 | $4.35 | $4.35K | 1,000 |
| David K. Neal Director | Apr 21, 2022 | Buy | +34,400 | $4.35 | $149.64K | 34,400 |
| William Wesemann Director | Apr 21, 2022 | Buy | +11,000 | $4.35 | $47.85K | 52,736 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.